ストックスクリーナーアプリを入手
3.87
4.88%
0.18
Neuroone Medical Technologies Corp (NMTC) 最新ニュース
NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance - Minichart
According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50 - Bitget
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 - Scott Coop
NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance - Stock Titan
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises - Investing.com
Maxim Group Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $13 - Moomoo
NMTC Maintains Buy Rating by Ladenburg Thalmann -- Price Target Raised to $8.80 - GuruFocus
NeuroOne Medical Tech Price Target Raised to $8.00/Share From $1.60 by Ladenburg Thalmann - Moomoo
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript - Sahm
NeuroOne Medical (NMTC) Price Target Raised to $8 - GuruFocus
Ladenburg Thalmann Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
NeuroOne Medical Technologies Corp 2026 Q2 Financial Report: Revenue, Product Updates, and Financial Statements - Minichart
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call - GuruFocus
Q2 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock dips - Investing.com India
Is NeuroOne Medical Technologies (NMTC) 42.2% Undervalued or a P - GuruFocus
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock dips By Investing.com - Investing.com Canada
NEUROONE MEDICAL TECHNOLOGIES Corp 2Q 2026: Revenue $2.39M, EPS ($0.25) — 10-Q Summary - TradingView
NeuroOne Medical | 10-Q: Q2 2026 Earnings Report - Moomoo
NeuroOne (NASDAQ: NMTC) grows sales but warns on going concern - Stock Titan
NeuroOne posts Q2 fiscal 2026: Product revenue $2.4M, net loss $2.1M - TradingView
NeuroOne (Nasdaq: NMTC) Q2 revenue jumps 72% while net loss persists - Stock Titan
EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update - FinanzNachrichten.de
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Repor - GuruFocus
NeuroOne Medical | 8-K: Current report - Moomoo
NeuroOne Medical Technologies Corp expected to post a loss of 23 cents a shareEarnings Preview - TradingView
NeuroOne Medical Technologies Corporation Receives Nasdaq Deficiency Notice for Minimum Bid Price Compliance – 8-K Filing April 30, 2026 - Minichart
NeuroOne (NASDAQ: NMTC) restores compliance with Nasdaq $1.00 bid rule - Stock Titan
NeuroOne Medical Technologies Announces CFO Transition and Release Agreement Filing - Minichart
EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Chief Financial Officer Succession Plan - FinanzNachrichten.de
CFO transition at NeuroOne (NASDAQ: NMTC) as Volker steps up - Stock Titan
NMTC Price Today: NeuroOne Medical Technologies Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time - Yahoo Finance
Pratts disclose 7.4% stake in NeuroOne Medical (NMTC) after reverse split - Stock Titan
NeuroOne (NMTC) Stock Breaking News (Smart Money Active) 2026-04-18Post Earnings - Xã Thanh Hà
NeuroOne Medical Technologies Hits New 52-Week High of $4.65 - Markets Mojo
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota - marketscreener.com
NMTC (NeuroOne Medical Technologies Corporation) reports sharp year over year revenue growth and narrower than expected losses to lift shares.Expert Verified Trades - newser.com
NeuroOne Medical Technologies announces 1-for-6 reverse stock split - Investing.com
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance - marketscreener.com
1-for-6 reverse split at NeuroOne (NASDAQ: NMTC) consolidates shares - Stock Titan
NMTC SEC FilingsNeuroone Med Technologies Corp 10-K, 10-Q, 8-K Forms - Stock Titan
If You Invested $1,000 in Neuroone Med Technologies Corp (NMTC) - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
NEUROONE (NASDAQ: NMTC) director granted options and 41,929 RSUs - Stock Titan
NMTC (NMTC) director gains new stock options and 41,929 RSUs - Stock Titan
Equity awards granted to NeuroOne (NMTC) director Paul Buckman - Stock Titan
NeuroOne (NMTC) director receives new RSU and stock option grants - Stock Titan
Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k - simplywall.st
Is NeuroOne (NMTC) Stock Near a Bottom | Price at $0.83, Up 4.40%Investment Signal Network - newser.com
NeuroOne Medical Technologies Corporation Adopts First Amendment to 2025 Equity Incentive Plan – SEC Form 8-K Filing Summary - Minichart
NeuroOne Medical Technologies shareholders approve reverse stock split and equity plan changes - Investing.com Australia
1.27%
2.05%
大文字化:
|
ボリューム (24 時間):